Schlossmacher Lab

A Parkinson's disease lab located at University of Ottawa. We focus on many different approaches to understand the pathogenesis of PD.

[Schlossmacher Lab @MGS_Lab]

Our story is out on @biorxivpreprint! Thank you to all of our coauthors and especially to the all the patients and their families that make human brain research possible. https://t.co/Rvstk0u4oD

[Schlossmacher Lab @MGS_Lab]

@veroniksicard @UOttawaPDA Thanks so much!

[Maxime Rousseaux @maximewc]

Congrats to Bojan from @MGS_Lab ! @uOttawaBMRI @OttawaHospital #OHRI

[The Science of Parkinson's @ScienceofPD]

Meta analysis suggests patients with various bacterial, viral, & fungal infections (Helicobacter pylori, hepatitis C virus, Malassezia, & pneumoniae) might have increased risk of #Parkinsons. Antiviral treatment of HCV could reduce the risk of PD
https://t.co/T0QfSA3Lo6

[Museum of Nature @MuseumofNature]

We are celebrating the timely Me and My Microbes exhibition @museumofnature with special announcement of funding from @CIHR_IRSC for microbiome research across Canada, including @UCalgary. Visit the exhibition until March 29.

[Schlossmacher Lab @MGS_Lab]

On Thursday night, some members of our lab attended the VIP event for the Me & My Microbes exhibit at the @MuseumofNature!

[Claire Bale she/her @Ladybale]

New @ParkinsonsUK research suggests that a bacteria which boosts digestive health can slow – and even reverse – the build-up of a protein associated with Parkinson’s.

👉Find out more at https://t.co/Usfq9gN1x4

[Schlossmacher Lab @MGS_Lab]

Our new #PhD student Michaela Lunn gave an oral presentation at the recent OHRI Research Day in November and took home the first place prize! Michaela studies the immune properties of PD-linked protein #LRRK2. @OttawaHospital

[Schlossmacher Lab @MGS_Lab]

Meet our senior #PhD candidate Daniel El Kodsi. Daniel has been producing exciting work in the Schlossmacher lab for many years. Stay tuned for exciting #firstauthor papers from Daniel coming soon!

[Schlossmacher Lab @MGS_Lab]

A word cloud from the final thesis of our Master's student, Christopher Rousso, who successfully defended his thesis in November. Chris has done exciting work on the role of alpha-synuclein in the #immunesystem both in the brain and the periphery.

[The Ottawa Hospital @OttawaHospital]

Dr. Michael Schlossmacher's research aims to unravel some of the mystery around #Parkinson’s, a disease for which there is no cure, or even a way to slow the progress.

His team's latest study is a step in that direction.

https://t.co/OPRlo3KuLp #onHWS @uOttawaBMRI @uottawa

[Schlossmacher Lab @MGS_Lab]

Take a look at our paper from 2017 to see our findings on possible anti-microbial effects of #alphasynuclein and an exciting new staining technique created by our lab

[The Science of Parkinson's @ScienceofPD]

@topdresearch David Beckham's lab has shown that alpha synuclein has antiviral properties ( https://t.co/oCyoPrxp7i ), & Michael Schlossmacher's lab has a similar line of research (https://t.co/YZuuctoARO). So this new PARKIN research is interesting from this standpoint as well

[TenderLovingResearch @TLROttawa]

Dr. Michael Schlossmacher speaking about Parkinson's research #letstalkparkinsons #tenderlovingresearch #TLR

[Schlossmacher Lab @MGS_Lab]

Please see our most recently published paper in #STM for exciting research connecting PD-linked protein LRRK2 with an important role in immune defences. We also identified an interesting #sexdifference.

[Science Translational Medicine @ScienceTM]

A gene that has been linked to #Parkinsons disease controls the course of certain bacterial and viral infections in mice in a sex-specific manner. Read the new research from @uOttawa. #InfectiousDisease https://t.co/y76w9d6qb7